These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26283460)

  • 1. Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study.
    Nam HY; Lee HY; Park GC
    Clin Otolaryngol; 2016 Aug; 41(4):358-64. PubMed ID: 26283460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
    Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY
    Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
    Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma.
    Hsieh CJ; Wang PW
    Thyroid; 2014 Mar; 24(3):488-93. PubMed ID: 23971786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.
    Ryu YJ; Yoon JH
    Surg Oncol; 2020 Sep; 34():67-73. PubMed ID: 32891356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
    Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
    J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.
    Jeong JS; Kim HK; Lee CR; Park S; Park JH; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    J Korean Med Sci; 2012 Aug; 27(8):883-9. PubMed ID: 22876054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Relationship Between IgG4-Positive Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma.
    Yu Y; Zhang J; Lu G; Li T; Zhang Y; Yu N; Gao Y; Gao Y; Guo X
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1516-24. PubMed ID: 26866571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy.
    Carvalho MS; Rosario PW; Mourão GF; Calsolari MR
    Endocrine; 2017 Mar; 55(3):954-958. PubMed ID: 27878772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy.
    Kuo SF; Chao TC; Chang HY; Hsueh C; Lin CL; Chiang KC; Chuang WY; Chen YC; Lin JD
    Asian J Surg; 2017 May; 40(3):186-192. PubMed ID: 26553529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study.
    Jia X; Pang P; Wang L; Zhao L; Jiang L; Song Y; Fan X; Wang Y; Zhao S; Ba J; Yang G; Wang X; Gu W; Zang L; Pei Y; Du J; Mu Y; Lyu Z
    Front Endocrinol (Lausanne); 2020; 11():452. PubMed ID: 32760349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma.
    Ernaga-Lorea A; Hernández-Morhain MC; Anda-Apiñániz E; Pineda-Arribas JJ; Migueliz-Bermejo I; Eguílaz-Esparza N; Irigaray-Echarri A
    Clin Transl Oncol; 2018 Jun; 20(6):740-744. PubMed ID: 29071517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.
    Kim WW; Ha TK; Bae SK
    J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):4. PubMed ID: 29316976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy.
    Côrtes MCS; Rosario PW; Mourão GF; Calsolari MR
    Braz J Otorhinolaryngol; 2018; 84(4):448-452. PubMed ID: 28625809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
    Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
    Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of changes in serum thyroglobulin antibody levels of pre- and post-total thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients.
    Tsushima Y; Miyauchi A; Ito Y; Kudo T; Masuoka H; Yabuta T; Fukushima M; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Kikumori T; Imai T; Kiuchi T
    Endocr J; 2013; 60(7):871-6. PubMed ID: 23585494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
    Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
    Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE SIGNIFICANCE OF THYROGLOBULIN ANTIBODIES IN PAPILLARY THYROID CANCER.
    Woeber KA
    Endocr Pract; 2016 Sep; 22(9):1132-3. PubMed ID: 27295018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.